Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Prerna Vatsa"'
Autor:
Seaho Kim, CheukMan C Au, Mohd Azrin Bin Jamalruddin, Naira Essam Abou-Ghali, Eiman Mukhtar, Luigi Portella, Adeline Berger, Daniel Worroll, Prerna Vatsa, David S Rickman, David M Nanus, Paraskevi Giannakakou
Publikováno v:
eLife, Vol 11 (2022)
Expression of the AR splice variant, androgen receptor variant 7 (AR-V7), in prostate cancer is correlated with poor patient survival and resistance to AR targeted therapies and taxanes. Currently, there is no specific inhibitor of AR-V7, while the m
Externí odkaz:
https://doaj.org/article/2dbc4df1b5624c61b2a0b3917507799c
Autor:
Mohd Azrin Bin Jamalruddin, CheukMan C Au, Seaho Kim, Naira Essam Abou-Ghali, Eiman Mukhtar, Luigi Portella, Adeline Berger, Daniel Worroll, Prerna Vatsa, David S Rickman, David M Nanus, Paraskevi Giannakakou
Publikováno v:
eLife. 11
Expression of the AR splice variant, androgen receptor variant 7 (AR-V7), in prostate cancer is correlated with poor patient survival and resistance to AR targeted therapies and taxanes. Currently, there is no specific inhibitor of AR-V7, while the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::418f30910e7a7fac0462defcdf0ab66c
https://doi.org/10.7554/elife.73396
https://doi.org/10.7554/elife.73396
Autor:
Mohd Azrin Bin Jamalruddin, CheukMan C Au, Seaho Kim, Naira Essam Abou-Ghali, Eiman Mukhtar, Luigi Portella, Adeline Berger, Daniel Worroll, Prerna Vatsa, David S Rickman, David M Nanus, Paraskevi Giannakakou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49018e5f726083f9728d18f7cf76fab7
https://doi.org/10.7554/elife.73396.sa2
https://doi.org/10.7554/elife.73396.sa2
Autor:
Giuseppe Galletti, Prerna Vatsa, Joseph R. Osborne, Neil H. Bander, David M. Nanus, Scott T. Tagawa, Paraskevi Giannakakou
Publikováno v:
Cancer Research. 82:1264-1264
Prostate specific membrane antigen (PSMA)-targeted radionuclide therapies (PSMA-TRTs) is one of the most promising treatments for metastatic castration-resistant prostate cancer (mCRPC) upon progression on androgen receptor signaling inhibitors (ARPi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::935503d1dd430feb977b8ed955a273a1
https://doi.org/10.1158/1538-7445.am2022-1264
https://doi.org/10.1158/1538-7445.am2022-1264
Autor:
CheukMan Cherie Au, Seaho Kim, Prerna Vatsa, Mohd Azrin Bin Jamalruddin, Michael Miller, Peter T. Meinke, Paraskevi Giannakakou
Publikováno v:
Cancer Research. 82:3946-3946
Castration resistance prostate cancer (CRPC) is a lethal disease in which the expression of ligand-independent androgen receptor (AR) splice variants (AR-Vs) is associated with worse clinical outcomes. AR-V7 is the most prevalent variant in CRPC, it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14ebcde386a035582b436c68b23091fa
https://doi.org/10.1158/1538-7445.am2022-3946
https://doi.org/10.1158/1538-7445.am2022-3946